175 related articles for article (PubMed ID: 23207960)
1. Design and in vitro evaluation of finasteride-loaded liquid crystalline nanoparticles for topical delivery.
Madheswaran T; Baskaran R; Thapa RK; Rhyu JY; Choi HY; Kim JO; Yong CS; Yoo BK
AAPS PharmSciTech; 2013 Mar; 14(1):45-52. PubMed ID: 23207960
[TBL] [Abstract][Full Text] [Related]
2. Design of Finasteride-Loaded Nanoparticles for Potential Treatment of Alopecia.
Roque LV; Dias IS; Cruz N; Rebelo A; Roberto A; Rijo P; Reis CP
Skin Pharmacol Physiol; 2017; 30(4):197-204. PubMed ID: 28689207
[TBL] [Abstract][Full Text] [Related]
3. Enhanced topical delivery of finasteride using glyceryl monooleate-based liquid crystalline nanoparticles stabilized by cremophor surfactants.
Madheswaran T; Baskaran R; Yong CS; Yoo BK
AAPS PharmSciTech; 2014 Feb; 15(1):44-51. PubMed ID: 24222268
[TBL] [Abstract][Full Text] [Related]
4. Finasteride Topical Delivery Systems for Androgenetic Alopecia.
Khan MZU; Khan SA; Ubaid M; Shah A; Kousar R; Murtaza G
Curr Drug Deliv; 2018; 15(8):1100-1111. PubMed ID: 29366416
[TBL] [Abstract][Full Text] [Related]
5. In Vitro and In Vivo Skin Distribution of 5α-Reductase Inhibitors Loaded Into Liquid Crystalline Nanoparticles.
Madheswaran T; Baskaran R; Yoo BK; Kesharwani P
J Pharm Sci; 2017 Nov; 106(11):3385-3394. PubMed ID: 28652158
[TBL] [Abstract][Full Text] [Related]
6. Transdermal finasteride delivery via powder-carrying microneedles with a diffusion enhancer to treat androgenetic alopecia.
Kim S; Eum J; Yang H; Jung H
J Control Release; 2019 Dec; 316():1-11. PubMed ID: 31689460
[TBL] [Abstract][Full Text] [Related]
7. Water-stable and finasteride-loaded polyvinyl alcohol nanofibrous particles with sustained drug release for improved prostatic artery embolization - In vitro and in vivo evaluation.
Li X; Li B; Ullah MW; Panday R; Cao J; Li Q; Zhang Y; Wang L; Yang G
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111107. PubMed ID: 32600710
[TBL] [Abstract][Full Text] [Related]
8. Topical formulations containing finasteride. Part I: in vitro permeation/penetration study and in vivo pharmacokinetics in hairless rat.
Monti D; Tampucci S; Burgalassi S; Chetoni P; Lenzi C; Pirone A; Mailland F
J Pharm Sci; 2014 Aug; 103(8):2307-14. PubMed ID: 24942358
[TBL] [Abstract][Full Text] [Related]
9. Transdermal film-loaded finasteride microplates to enhance drug skin permeation: Two-step optimization study.
Ahmed TA; El-Say KM
Eur J Pharm Sci; 2016 Jun; 88():246-56. PubMed ID: 26993962
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical Characterization of Finasteride Nanosystem for Enhanced Topical Delivery.
Irfan MM; Shah SU; Khan IU; Munir MU; Khan NR; Shah KU; Rehman SU; Sohaib M; Basit HM; Mahmood S
Int J Nanomedicine; 2021; 16():1207-1220. PubMed ID: 33623383
[TBL] [Abstract][Full Text] [Related]
11. Enhanced skin permeation of 5α-reductase inhibitors entrapped into surface-modified liquid crystalline nanoparticles.
Madheswaran T; Baskaran R; Sundaramoorthy P; Yoo BK
Arch Pharm Res; 2015 Apr; 38(4):534-42. PubMed ID: 25085659
[TBL] [Abstract][Full Text] [Related]
12. A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women.
Lee SW; Juhasz M; Mobasher P; Ekelem C; Mesinkovska NA
J Drugs Dermatol; 2018 Apr; 17(4):457-463. PubMed ID: 29601622
[TBL] [Abstract][Full Text] [Related]
13. Chitosan-decorated polystyrene-b-poly(acrylic acid) polymersomes as novel carriers for topical delivery of finasteride.
Caon T; Porto LC; Granada A; Tagliari MP; Silva MA; Simões CM; Borsali R; Soldi V
Eur J Pharm Sci; 2014 Feb; 52():165-72. PubMed ID: 24262075
[TBL] [Abstract][Full Text] [Related]
14. Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies.
Gomes MJ; Martins S; Ferreira D; Segundo MA; Reis S
Int J Nanomedicine; 2014; 9():1231-42. PubMed ID: 24634584
[TBL] [Abstract][Full Text] [Related]
15. Impact of formulation design and lyophilisation on the physicochemical characteristics of finasteride nanosystems.
Irfan MM; Shah SU; Shah KU; Anton N; Idoux-Gillet Y; Conzatti G; Shah KU; Perennes E; Vandamme T
J Microencapsul; 2023 Mar; 40(2):106-123. PubMed ID: 36749573
[TBL] [Abstract][Full Text] [Related]
16. Preparation and optimization of aloe ferox gel loaded with Finasteride-Oregano oil nanocubosomes for treatment of alopecia.
Hosny KM; Rizg WY; Alfayez E; Elgebaly SS; Alamoudi AJ; Felimban RI; Tayeb HH; Mushtaq RY; Safhi AY; Alharbi M; Almehmady AM
Drug Deliv; 2022 Dec; 29(1):284-293. PubMed ID: 35019794
[TBL] [Abstract][Full Text] [Related]
17. Development of liposomal systems of finasteride for topical applications: design, characterization, and in vitro evaluation.
Kumar R; Singh B; Bakshi G; Katare OP
Pharm Dev Technol; 2007; 12(6):591-601. PubMed ID: 18161632
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effect of tacrolimus-loaded liquid crystalline nanoparticles on psoriasis-like skin inflammation.
Thapa RK; Yoo BK
J Dermatolog Treat; 2014 Feb; 25(1):22-5. PubMed ID: 23210668
[TBL] [Abstract][Full Text] [Related]
19. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
[TBL] [Abstract][Full Text] [Related]
20. Topical formulations containing finasteride. Part II: determination of finasteride penetration into hair follicles using the differential stripping technique.
Tampucci S; Burgalassi S; Chetoni P; Lenzi C; Pirone A; Mailland F; Caserini M; Monti D
J Pharm Sci; 2014 Aug; 103(8):2323-9. PubMed ID: 24916447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
